![]() |
|||
|
|
|
|
| UPDATE: November 2007 | MW: 406.61 | MF: C27H34O3 |
SYNONYMS:
|
|
| |
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
N/R
|
N/R
|
N/R
|
N/R
|
| |||
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intramuscular | mouse
lowest published toxic dose: 15 mg/kg (7-12 day pregnant)
|
Reproductive: Specific developmental abnormalities: Musculoskeletal system | Reproductive: Specific developmental abnormalities: Urogenital system Reproductive: Effects on newborn: Live birth index (Litter size (e.g., # fetuses per litter; measured after birth)
OYYAA2 7,723,1973
|
intramuscular | mouse
lowest published toxic dose: 15 mg/kg (7-12 day pregnant)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
|
OYYAA2 7,723,1973
|
intramuscular | mouse
lowest published toxic dose: 60 mg/kg (7-12 day pregnant)
|
Reproductive: Specific developmental abnormalities: Eye, ear
|
OYYAA2 7,723,1973
|
intramuscular | mouse
lowest published toxic dose: 240 mg/kg (7-12 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Effects on newborn: Weaning or lactation index (e.g., # alive at weaning per # alive at day 4)
OYYAA2 7,723,1973
|
intramuscular | rat
lowest published toxic dose: 1,400 µg/kg (14 day male)
|
Reproductive: Paternal effects: Testes, epididymis, sperm duct
|
ARZNAD 23,907,1973
|
intramuscular | rat
lowest published toxic dose: 3,750 µg/kg (9-14 day pregnant)
|
Reproductive: Specific developmental abnormalities: Musculoskeletal system | Reproductive: Specific developmental abnormalities: Urogenital system Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
OYYAA2 7,723,1973
|
intramuscular | rat
lowest published toxic dose: 15 mg/kg (9-14 day pregnant)
|
Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) Reproductive: Effects on newborn: Live birth index (Litter size (e.g., # fetuses per litter; measured after birth)
OYYAA2 7,723,1973
|
oral | rat
lowest published toxic dose: 14,850 µg/kg (11 day male)
|
Reproductive: Paternal effects: Prostate, seminal vesicle, Cowper's gland, accessory glands
|
ARZNAD 26,1673,1976
|
subcutaneous | mouse
lowest published toxic dose: 1,200 µg/kg (3 day prior to copulation)
|
Reproductive: Maternal effects: Uterus, cervix, vagina
|
ARZNAD 23,907,1973
|
subcutaneous | rat
lowest published toxic dose: 60 mg/kg (7-12 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants)
|
STEDAM 18,731,1971
|
subcutaneous | rat
lowest published toxic dose: 600 mg/kg (17-20 day pregnant)
|
Reproductive: Specific developmental abnormalities: Urogenital system
|
AVBIB9 13,71,1974
|
| |||
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | mouse
lethal dose (50 percent kill): >1 gm/kg
|
N/R
|
NIIRDN 6,541,1982
|
intraperitoneal | rat
lethal dose (50 percent kill): 595 mg/kg
|
N/R
|
PCJOAU 20,143,1986
|
| |||
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
TOXICOLOGY REVIEW
|
|
BIREBV 8,259,1973
|
TOXICOLOGY REVIEW
|
|
TOLED5 158,167,2005
|
| ||
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Occupational Exposure Limit - RUSSIA
|
short term exposure limit 0.005 mg/m3, JUN2003
|
| |||
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: X5317 |
Number of Industries 1; Total Number of Facilities 7; Number of Occupations 2; Total Number of Employees Exposed 628; Total Number of Female Employees Exposed 314 | |||
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
N/R
|
| ||
REFERENCES:
CODEN
|
|
REFERENCE
ARZNAD
|
Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960
Aulendorf, Fed. Rep. Ger.) V.1- 1951-
|
AVBIB9
|
Advances in the Biosciences. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY
10523) V.1- 1967-
|
BIREBV
|
Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL
61820) V.1- 1969-
|
NIIRDN
|
Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan)
|
OYYAA2
|
Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1-
1967-
|
PCJOAU
|
Pharmaceutical Chemistry Journal (English Translation). Translation of KHFZAN. (Plenum Pub.
Corp., 233 Spring St., New York, NY 10013) No.1- 1967-
|
STEDAM
|
Steroids. (Holden-Day Inc., 4432 Telegraph Ave., Oakland, CA 94609) V.1- 1963-
|
TOLED5
|
Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands)
V.1- 1977-
|
| |